PREFER: A Study to Describe Patient REal-world FitusiRan ExpeRience (clinicaltrials.gov) - Oct 27, 2026 - P=N/A | N=100 | Not yet recruiting | Sponsor: Sanofi
New trial • Real-world evidence • Hematological Disorders • Hemophilia • Hemophilia A • Hemophilia B • Rare Diseases
|